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Abstract
Background: The past 10 years have witnessed a significant growth in sharing of health data for secondary uses.
Alongside this there has been growing interest in the public acceptability of data sharing and data linkage
practices. Public acceptance is recognised as crucial for ensuring the legitimacy of current practices and systems of
governance. Given the growing international interest in this area this systematic review and thematic synthesis
represents a timely review of current evidence. It highlights the key factors influencing public responses as well as
important areas for further research.
Methods: This paper reports a systematic review and thematic synthesis of qualitative studies examining public
attitudes towards the sharing or linkage of health data for research purposes. Twenty-five studies were included in
the review. The included studies were conducted primarily in the UK and North America, with one study set in
Japan, another in Sweden and one in multiple countries. The included studies were conducted between 1999 and
2013 (eight studies selected for inclusion did not report data collection dates). The qualitative methods represented
in the studies included focus groups, interviews, deliberative events, dialogue workshops and asynchronous online
interviews.
Results: Key themes identified across the corpus of studies related to the conditions necessary for public support/
acceptability, areas of public concern and implications for future research. The results identify a growing body of
evidence pointing towards widespread general—though conditional—support for data linkage and data sharing for
research purposes. Whilst a variety of concerns were raised (e.g. relating to confidentiality, individuals’ control over
their data, uses and abuses of data and potential harms arising) in cases where participants perceived there to be
actual or potential public benefits from research and had trust in the individuals or organisations conducting and/
or overseeing data linkage/sharing, they were generally supportive. The studies also find current low levels of
awareness about existing practices and uses of data.
Conclusions: Whilst the results indicate widespread (conditional) public support for data sharing and linkage for
research purposes, a range of concerns exist. In order to ensure public support for future research uses of data
greater awareness raising combined with opportunities for public engagement and deliberation are needed. This
will be essential for ensuring the legitimacy of future health informatics research and avoiding further public
controversy.
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Background
Since the publication of the World Medical Association’s
Declaration on Ethical Considerations regarding Health
Databases in 2002, which stated that “databases are valu-
able sources of information” for health research, quality
assurance and risk management [1] there has been
steady and significant growth in the sharing of health
data for ‘secondary uses’. The Medical Research Council
(MRC) and Wellcome Trust ([2], p.6) note that “recent
years have brought many calls for the optimisation of
data sharing for research, with the intention of deriving
maximal societal benefit”.
Recently this commitment to expanding research uses
of data has led to growing interest in the public accept-
ability of data sharing and data linkage practices (e.g. [3]).
This relates, in part, to the recognition of the importance
of ensuring that data uses align with public interests or
preferences. Recent highly publicised controversies (for
example relating to care.data in England) have drawn
attention to the importance of ensuring public support for
the ways that data are used. Thus, there is increasing
attention to public acceptability of secondary uses of data
and to ensuring that these uses are understood and sup-
ported by the wider public (from whom the data origin-
ate). This may be crucial for ensuring the legitimacy of
current practices and systems of governance. As Bradwell
and Gallagher [4] have suggested; “personal information
use needs to be far more democratic, open and trans-
parent” and this means “giving people the opportunity
to negotiate how others use their personal informa-
tion in the various and many contexts in which this
happens” (pp:18–19).
Previously it was noted that the literature in this area
was dominated by practitioner perspectives and public
views were underrepresented or underreported [5].
However, over the last decade there has been a steady
increase in the number of studies exploring public atti-
tudes or acceptability of secondary uses of data. Such
studies have been conducted in a range of contexts and
in relation to various research practices. Qualitative
studies in the field of medical and healthcare research
have, historically, tended to receive less attention than
quantitative studies. However, despite qualitative studies
usually being based on small sample sizes that prohibit
claims to being statistically representative [6, 7], they
can provide rich insights and a deeper understanding of
the complexities or nuances of public opinions and expe-
riences. They also allow for public views to be interpreted
in a way that can effectively inform policy and practice is-
sues [8]. Recently, reports discussing public views toward
data sharing or data linkage for research purposes have
principally used qualitative methods [3, 9, 10], exem-
plifying the value of such approaches for exploring
the challenges and complexities of this topic.
Data-sharing and data-linkage refer to two distinct
processes which are used in different ways. Data-sharing
involves information moving from one organisation or
department to another, whereas data-linkage is defined
as: “the bringing together from two or more different
sources, data that relate to the same individual, family,
place or event” [11]. Increasing amounts of health re-
search are conducted through data-linkage, for example
health related records have been linked with population
registries [12], alcohol and drugs services [11], genea-
logical registries [11], the census [13, 14]), the education
system [15] and the prison service [16]. Such linkages
have enabled, among other things, examination of rela-
tionships between social factors and health or access to
health services.
This paper reports the results of a systematic review
and thematic synthesis of qualitative studies which have
explored public attitudes to data-sharing or data-linkage
for research purposes. The study aimed to address the
following research question:
What are the key issues of public responses in data-
sharing and data linkage for research, and how have
these been characterised?
This paper reports key themes that have emerged
through this thematic synthesis and discusses their rele-
vance for current debates around secondary uses of data
for health research. Given the growing international
interest in this area this represents a timely review of
current evidence. It highlights the key factors influencing
public responses and in doing so identifies particular
topics of salience which it will be important to examine
further.
Throughout this paper the terms ‘review’, ‘researcher(s)’,
‘participant(s)’ and ‘author(s)’ will be used to refer to this
systematic review, the authors of the included studies, the
research participants of each study and the authors of this
paper, respectively.
Methods
Search strategy and inclusion criteria
A systematic literature search was conducted of five
electronic databases (CINAHL Plus, EMBASE, Medline,
Scopus and Web of Science) on 4 April 2014. Table 1
displays the key search terms that were tailored for all
databases using both free-text terms and subject head-
ings where possible (see Appendix 1 for an adapted
search strategy for Medline). In addition, searches were
conducted through Google Scholar and Open Grey as
well as scanning references of included papers and
contacting experts for a more inclusive result. There
were no limitations on publication dates, languages or
geographical locations.
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The initial database searches revealed 1502 papers.
Two authors (M.A. and J.S.J.) separately screened titles
and abstracts and read eligible full texts before recon-
vening to discuss their results and resolve any discrepan-
cies. Figure 1 shows the search and selection outcomes
for each stage of the process. An additional 19 papers
were identified through other sources (hand-searching
references, expert communications and grey-literature
searches). Papers were included if they met all inclusion
criteria (see Table 2).
Quality appraisal and data extraction
Each included study was individually appraised and data
were extracted by the same two authors. Table 3 displays
the main characteristics of each study including the
study aim, date of data collection, setting, sample char-
acteristics, sampling and method of data collection. The
Critical Appraisal Skills Programme [17] checklist was
used to critically assess the qualitative research. It was
agreed that all studies were of sufficient quality to be in-
cluded in the study. The CASP checklist represented a
valuable tool for facilitating critical reflection on each of
the studies.
Synthesis
A thematic synthesis approach was adopted using
Thomas and Harden’s [18] three-step technique: Free
line-by-line coding of the included studies, the emer-
gence of descriptive themes from the codes and the de-
velopment of analytical themes. Independently, M.A.
and J.S.J. coded the included studies using an inductive
approach without a priori codes.
All authors met to discuss the codes/themes and to re-
solve any discrepancies. Three authors (R.J., C.P. and
S.C.B.) were each assigned three articles (totalling nine)
from the included studies to validate the findings of
M.A. and J.S.J. At this stage ten further studies were
excluded from the synthesis for not reporting partici-
pants’ verbatim views or first-order constructs (Britten
et al. 2002); not reporting detailed qualitative findings
(Sandelowski and Barroso 2003); not reporting find-
ings relevant to the research topic; or for not includ-
ing public responses. A list of descriptive themes
(referred to as ‘sub’ themes) were agreed and orga-
nised by analytical (‘key’) themes. The key themes were
identified and interpreted in relation to the research ques-
tion (see Table 4). From the included studies, M.A. and
J.S.J. extracted first- and second-order constructs (the lat-
ter being the original researchers’ interpretations of the
participants’ constructs) including any reciprocal or refuta-
tional translations (comparable or opposing views) [19].
While three authors (M.A., S.C.B. and C.P.) work dir-
ectly in the field of public engagement regarding health
informatics research, the remaining two authors (J.S.J.
and R.J.) were not previously familiar with the literature
or debates in this area. The involvement of authors with-
out prior understandings or perspectives on the litera-
ture was valuable for ensuring an inductive approach.
The authors discussed and deliberated the coding and
analysis to ensure that the findings emerged from the in-
cluded studies rather than being shaped by or confirm-
ing the expectations of authors who are actively engaged
in this subject matter.
Results
Included Studies
A total of 1521 studies were identified from the system-
atic searches. From these, 25 studies were included in
the review. The research was conducted primarily in the
UK (five studies in Scotland, four in England, one in
Wales and two across the UK) and in North America
(seven studies in the USA and three in Canada) with one
study set in Japan, another in Sweden and one worldwide.
Data was collected from 1999 to 2013, though eight stud-
ies did not report data collection dates. The research par-
ticipants included patients, service users, carers, surrogate
decision-makers, lay persons and the general public
ranging from 18 years of age to over 75 years. Six studies
reported expert opinions from healthcare professionals,
managers, health service staff and diabetes specialists in
addition to the views of members of the wider public or
patient groups. The qualitative methods of data collection
included focus groups, interviews, deliberative events,
dialogue workshops and asynchronous online interviews.
Six studies included mixed methods using surveys or
structured questionnaires. Additionally, three studies re-
ported both primary and secondary research including a
literature or policy review or systematic review.
Table 1 Key search terms
(lay OR patient* OR public OR citizen$1)
AND
(attitude* OR view$1 OR perspective* OR opinion$1)
AND
(data OR record$1)
AND
(share$ OR sharing OR link$2 OR linkage)
AND
Research
AND
(access OR purpose$1)
AND
(qualitative OR ethnograph* OR “grounded theory” OR “in depth
interview$1” OR “structured interview$1” OR “focus group$1” OR “case
study” OR “case studies” OR “case series” OR “citizen$2 juries” OR
vignette* OR observation*)
□ Asterisks (“*”) are used as a wildcard to allow for any given search
term to be truncated or remain the same.
□ Dollar signs (“$”) followed by a number refer to the number of
additional characters allowed for each selected term.
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Seven key themes were identified across the included
studies: Widespread Conditional Support; Conditions for
Support; Benefits; Control and Consent; Uses and
Abuses of Data; Private Sector Involvement; and Trust
and Transparency.
Key Themes
Widespread Conditional Support
The included studies point to a clear trend that there
was generally widespread—albeit conditional—support
for uses of data in health research.1 This is typically
expressed in relation to a view that health research—or
research more broadly—is “in the public interest” or is
expected to bring about benefits for “the greater good”.2
For example, one participant in study number 25 stated:
“I think the medical research is going to be of general
benefit to the general population and if my records
can help; I think personally I would be quite willing to
participate in any medical study that is of general benefit
to the population. I just feel it is worthwhile to participate
in these studies” (Patient 4, Willison et al. 2003: 2)
Uses of data for health or medical research were often
conceptualised in relation to the potential for discovery
of new cures or treatments, or the improvement of
healthcare services.
Fig. 1 Selection process based on PRISMA flow diagram
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In several studies participants were reported as being
surprised that data are not already more widely used,
with questions being asked such as: “Doesn’t this happen
already?!”.3 Many studies reported that participants con-
sidered research uses of data to be in the public interest
and conversely that not using data was against the public
interest since this was a resource which should be used,
not wasted.4
Despite broad agreement that using health data for
medical research is generally a good thing, across the
studies it is evident that support for these data uses was
never unconditional. A number of factors were identified
as being important conditions for public support or
acceptance.
Conditions for Support
In a large number of studies assurances of individuals’
confidentiality were reported as crucial for public sup-
port.5 Whilst confidentiality may be assured through
various mechanisms, in the included studies this was
largely associated with anonymisation of data. Public
preferences for data to be anonymous were widely re-
ported,6 for example in one study7 a participant stated:
“[The public need] reassurance about anonymity
because that’s what people worry about”
Some individuals expressed a view that if the data are
anonymous “what does it matter?!”.8 However, others
noted that anonymisation is not an absolute guarantee
of confidentiality 9 and in a number of studies partici-
pants recognised that the anonymisation process is im-
perfect and therefore did not fully or adequately protect
individuals’ confidentiality.10 For example, it was said:
“I think you’re right enough, it’s anonymised. But then
if you’re dealing with particular areas, that again kind
of cuts in to the anonymous factor, because if you’re
looking at maybe, let’s say, a housing estate, so there’s
only so many people, so it’s not…I don’t think there’s
anything that’s truly anonymous; I think everything
can be found out if you’ve got the wherewithal and the
curiosity to find things out.”11
In a number of studies participants made a distinction
between “plain stats” and more detailed qualitative infor-
mation, with the former largely considered not to be
concerning while the latter raised greater issues relating
to confidentiality and privacy.12
Assurances of safeguards to protect against misuse or
abuse of data were also widely considered important for
ensuring public support/acceptability.13 Similarly,
members of the public often expressed a preference
for strong accountability mechanisms to be in place.14
However, there was generally found to be low public
awareness of current research practices15 and in par-
ticular, of current governance or ethics processes.16
As such, in a number of studies it was reported that
public acceptance increased after participants were
informed about existing safeguards and governance
mechanisms.
Assurances of data security were also found to be im-
portant for public acceptance of the use of health data in
research17 and across the studies concerns about data
security were widely identified.18 Such concerns related
to the fallibility of IT systems to protect against
breaches19 as well as to human error. Media reports of
“laptops left on trains” or misplaced data were widely
called upon to illustrate this latter point.20 However, in a
Table 2 Inclusion and exclusion criteria
Inclusion Criteria Exclusion Criteria
Study Design All studies based on primary evidence.
All studies reporting qualitative research relevant to the
phenomenon [37] including, but not limited to: focus
groups, in-depth interviews, case studies, vignettes,
citizens’ juries, ethnographic observation, field notes.
Mixed methods studies with a qualitative component
that applied qualitative methods to collect and
synthesise the research were included if the findings
were presented separately from the quantitative data.
All studies that included first-order constructs directly
reporting participants’ responses, such as quotations [19].
All qualitative studies that provided exploratory,
descriptive and/or explanatory findings [38].
All studies based on secondary evidence.
All studies that were solely based on quantitative research.
All studies that did not include first-order constructs
directly reporting participants’ responses, such as
quotations [19].
Study Population All studies researching public (including patient/lay)
perspectives.
Studies involving public and expert opinions were
included if public and expert responses were reported
separately.
All studies that did not report public perspectives.
Research Topic All studies that discussed the sharing and linkage
of data in research.
All studies that did not discuss the sharing and linkage of
data in research.
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Table 3 Study characteristics
No. Reference Study aim Date of data collection Setting Sample (N, gender, age) Sampling Method of data collection
1 Aitken, M., 2011, Linking
Social Care, Housing and
Health Data: Social care
clients’ and patients’ views
Scottish Government Social
Research
To explore the perspectives of
social care clients, patients and
carers in regards to linking
social care, housing support
and health data in statistical
research and their views of
possible impacts on privacy.
May 2011 (comparative
study with data collected
between October 2010
and February 2011).
North Ayrshire,
Edinburgh and
Tayside; Scotland
Patients, service users, carers and
the wider public (N = 20): 85 %
female and 57 % over the age of
60 (70–79 years = 14 %; 60–69
years = 43 %; 50–59 years =14 %;
40–49 years = 5 %; no reported
age = 24 %). Over half (60 %) of
the sample stated they suffered
from a health problem or
disability for at least 12 months.
- A series of consumer
panels (N = 3) involving
semi-structured group
discussions
2 Asai, A., Ohnishi, M.,
Nishigaki, E., Sekimoto, M.,
Fukuhara, S., & Fukui, T, 2002,
‘Attitudes of the Japanese
public and doctors towards
use of archived information
and samples without
informed consent:
Preliminary findings based
on focus group interviews’
BMC Medical Ethics 3(1): 1
To explore lay attitudes toward
the use of archived health
materials and to compare their
views with those of physicians
involved in medical research.
November 2000 Osaka, Japan Men of the general public (N = 7),
women of the general public
(N = 7), and male physicians
(N = 7), all between 35 and
55 years old (members of the
general public were married with
children)
- Focus-group interviews
(n = 3), one for each
sample group
3 Bond, C. S., Ahmed, O. H.,
Hind, M., Thomas, B., &
Hewitt-Taylor, J., 2013, ‘The
conceptual and practical
ethical dilemmas of using
health discussion board
posts as research data’
Journal of Medical Internet
Research 15(6)
To explore the perspectives of
contributors to online diabetes
discussion boards to better
understand their opinions
towards how their shared
information should be used by
health researchers.
April to May 2012 World Wide Web People living with diabetes who
use online discussion boards
(N = 26): male (N = 12), female
(N = 9), unknown (N = 6).
- Online semi-structured
asynchronous email
interviews
4 Damschroder, L. J., Pritts, J. L.,
Neblo, M. A., Kalarickal, R. J.,
Creswell, J. W., & Hayward, R.
A., 2007, ‘Patients, privacy
and trust: Patients’
willingness to allow
researchers to access their
medical records’ Social
Science & Medicine
64(1):223-235
To better understand why
there was wide variation in
consent process
recommendations despite a
high inclination to share
medical records for research.
November 2003 to June
2004
Four diverse
Veteran Affairs (VA)
facilities, USA
Patients from 4 Veterans Affairs
facilities (N = 217); 95 % male;
37 % minorities; average age was
65 years.
Random and
purposive
sampling,
stratifying for
clinic visits, age
and race/
ethnicity
Mixed methods:
Deliberation sessions
(N = 39), preceded by a
baseline-phone-
administered survey and
proceeded by another
phone administered
survey 4–6 weeks after
the deliberation session.
5 Davidson, S., McLean, C.,
Cunningham-Burley, S. &
Pagliari, C. 2012, Public
Acceptability of Cross-Sectoral
Data Linkage: Deliberative
research findings Scottish
Government Social Research
To explore public opinion on
the acceptability of linking
personal data for statistical and
research purposes, by
identifying particular sensitivities
and possible barriers to public
confidence and exploring ways
to overcome concerns.
26 May to 9 June 2012 Stirling, Inverness
and Glasgow;
Scotland
Members of the public (N = 73):
Male (N = 35); female (N = 38).
Age groups: 18–34 years (N = 25),
35–49 years (N = 23) and 50+
years (N = 25).
Quota sampling Series of public
deliberative event: Half-
day workshops were held
in each location (N = 3).
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Table 3 Study characteristics (Continued)
6 Davidson, S., McLean, C.,
Treanor, S., Aitken, M.,
Cunningham-Burley, S.,
Laurie, G., Pagliari, C & Sethi,
N., 2013, Public Acceptability
of Data Sharing Between the
Public, Private and Third
Sectors for Research
Purposes (Social Research
series). Scottish Government
To build on previous research,
existing literature and practical
examples to better understand
the issues related to data
sharing across the public,
private and third sectors for
statistical and research
purposes.
Oban - 29 June 2013;
Aberdeen - 6 July 2013;
Glasgow - 13 July 2013;
Galashiels - 20 July 2013;
and Edinburgh - 3
August 2013.
Oban, Aberdeen,
Glasgow,
Galashiels and
Edinburgh;
Scotland
Participants attending the general
public workshops (N = 105): Men
(N = 52) and women (N = 53). Age
bands: 18–34 years (N = 28); 35–
49 years (N = 32); and 50+ years
(N = 35). Pregnant/child < 1 year
old (N = 13). Participants
attending the LGBT workshop
(N = 12): Men (N = 6) and women
(N = 6). Age bands: 18–34 years
(N = 5); 35–49 years (N = 5); 50+
years (N = 2).
Quota sampling Primary and secondary
research methods:
Literature reviews (N = 2)
and a series of
deliberative events
(4 half-day events with
members of the general
public and a separate,
smaller scale event of
LGBT people).
7 Grant, A., Ure, J., Nicolson, D.
J., Hanley, J., Sheikh, A.,
McKinstry, B., & Sullivan, F.,
2013, ‘Acceptability and
perceived barriers and
facilitators to creating a
national research register to
enable 'direct to patient'
enrolment into research: the
Scottish Health Research
Register (SHARE)’ BMC Health
Services Research 13(1): 422
To explore patients’, clinicians’,
healthcare management staff
and researchers’ acceptability
and feasibility of the national
research register model to
better understand their
perspectives on the main
facilitators and barriers to
engagement in research.
Between February and
June 2011
Local health
centres in Tayside
and Lothian areas
in Scotland
Patients (N = 37); health service
researchers (N = 10); general
practitioners and practice
managers (N = 17).
Purposive and
convenience
sampling
Focus groups with
patients (N = 7); additional
focus group with health
service researchers (N = 1);
semi-structured interviews
with health service staff
(N = 17).
8 Haddow, G., Bruce, A.,
Sathanandam, S., & Wyatt, J.
C., 2011, ‘‘Nothing is really
safe’: a focus group study on
the processes of anonymizing
and sharing of health data for
research purposes’ Journal of
Evaluation in Clinical Practice
17(6): 1140-1146
To explore lay opinions about
the anonymisation and data-
sharing processes to Scotland’s
‘warehouse’ model and to
discuss whether consent is
necessary.
May and June 2009 North East of
Scotland
Lay participants from the Public
Partnership Group (N = 19): Males
(N = 6); females (N = 12); 1
participant did not reveal their
gender. Ages 75 and over (N = 3);
ages 60 to 74 (N = 15); ages 60
and under (N = 1). Participants
with a chronic health condition
(N = 13, 68 %).
- Focus groups (N = 3).
9 Haga, S. B., & O’Daniel, J.,
2011, ‘Public perspectives
regarding data-sharing
practices in genomics
research’ Public Health
Genomics 14(6): 319
To explore public attitudes,
predominantly of African
Americans, toward data sharing
in genetic and/or genomic
research and the possible
impact of said practices on
research involvement.
February 2008 to
February 2009
Various locations
across Durham,
North Carolina,
USA
Total participants (N = 100): 73 %
female; 76 % African-American;
median age of 40–49 years; 26 %
had some college education but
no degree.
- Mixed methods: Focus
groups (N= 10) ending
with a survey.
10 Hill, E. M., Turner, E. L., Martin,
R. M., & Donovan, J. L., 2013,
‘“Let’s get the best quality
research we can”: public
awareness and acceptance of
consent to use existing data in
health research: a systematic
review and qualitative study’
BMC Medical Research
Methodology 13(1): 72
To determine the varying
opinions of the public regarding
the use of existing medical data
for research and to explore their
views on consent to a
secondary review of medical
records for research purposes.
- Dorset, England Older male participants (N = 19):
Ages 54 to 69 years; mean age
61 years; White British (N = 18)
and White Other (N = 1).
Random
sampling
Primary and secondary
research methods:
Systematic review (N = 1)
and focus groups (N = 3).
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Table 3 Study characteristics (Continued)
11 Ipsos MORI, 2014, Dialogue on
Data: Exploring the public’s
views on using linked
administrative data for
research purposes HYPERLINK
"https://www.ipsos-mori.com/
DownloadPublication/
1657_sri-dialogue-on-data-
2014-census.pdf" www.ipsos-
mori.com
To explore public views of the
use of government
administrative data in social
research and to determine
what kind of procedures,
concepts and language are
needed to be applied to build
public confidence in the safety
and security of the linking of
their public records.
October to November
2013
England (London,
King’s Lynn and
Manchester), Wales
(Cardiff and
Wrexham),
Scotland (Stirling),
Northern Ireland
(Belfast).
Public members (N = 129) and
experts (N = 20).
Quota sampling Seven sets of reconvened
public dialogue workshops
(N = 14 in total)
12 McGuire, A. L., Hamilton, J. A.,
Lunstroth, R., McCullough, L.
B., & Goldman, A., 2008, ‘DNA
Data Sharing: research
participants' perspectives’
Genetics in Medicine
10(1): 46-53
To explore research
participants’ attitudes and
judgments toward data release
and their preferences for
differing levels of control over
decision-making through three
alternative types of consent
(traditional, binary and tiered).
- USA Patients and controls (N = 15)
from a genetic study on epilepsy.
Age ranges of 18–70 years;
females (N = 11); males (N = 4).
Age bands 46–55 years and
56–65 years had the most
participants for both focus-group
sessions. Most participants had
prior experience with medical
research (N = 13).
- Focus-group sessions
(N = 3) containing both
cases and control.
13 Melas, P. A., Sjöholm, L. K.,
Forsner, T., Edhborg, M., Juth,
N., Forsell, Y., & Lavebratt, C.,
2010, ‘Examining the public
refusal to consent to DNA
biobanking: empirical data
from a Swedish population-
based study’ Journal of
Medical Ethics 36(2): 93-98
To empirically explore the
motivations for not consenting
to DNA biobanking in a
population-based study and to
examine the implications.
A longitudinal
epidemiological project
(PART) ongoing since
1998. The DNA-collection
wave took place from
2006 to 2007.
Stockholm,
Sweden
Participants from a longitudinal
epidemiological project that had
declined to contribute saliva
samples for the DNA-collection
wave. Participants interviewed
(n = 23). Participants in ‘interview
subgroup 1’ (N = 15): men (N = 8),
mean age 48 years, range 33–61
years; women (N = 7), mean age
47 years, range 38–69 years. Par-
ticipants in ‘interview subgroup II’
(N = 8): men (N = 4), mean age
49.7 years, range 34–68 years;
women (N = 4), mean age
48.7 years, range 38–69 years. In-
dividuals completing the non-
participation questionnaire (N =
903).
- Mixed methods:
longitudinal population-
based study (PART) of
structured questionnaires
and semi-structured
interviews (N = 23).
14 MRC & Ipsos MORI, 2007, The
Use of Personal Health
Information in Medical
Research: General Public
Consultation - Final Report
HYPERLINK "http://
www.mrc.ac.uk"
www.mrc.ac.uk
To identify public concerns
and misconceptions in relation
to the secondary use of
personal health information for
medical research.
29 July 2006 - public
workshops in London
and Cardiff; 5 August
2006 - general workshop
in Edinburgh; 14 to 18
September 2006 - large-
scale quantitative survey
London, Cardiff
and Edinburgh; UK
Workshop participants reflecting
the general public (N = 63).
Interviews with disabled people
and people with long-term/
chronic conditions or their carers
(N = 6). A nationally representative
sample completed the survey
(N = 2106).
Quota sampling Mixed methods: general
public workshops (N= 3),
in-depth interviews over
the telephone (N= 6) and
a large-scale quantitative
survey.
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Table 3 Study characteristics (Continued)
15 Nair, K., Willison, D., Holbrook,
A., & Keshavjee, K., 2004,
‘Patients' consent preferences
regarding the use of their
health information for
research purposes: a
qualitative study’ Journal of
Health Services Research &
Policy 9(1): 22-27
To investigate the consent
preferences of patients whose
de-identified health data are
presently being used in
research.
March 1999 to May 2000 Hamilton area,
Ontario, Canada
Patients (N = 17): Male (N = 6);
female (N = 11); mean age was
52 years. Patients had been with
their physician for an average of
10 years. The median number of
physician visits were 4/year.
Convenience
sampling
Individual semi-structured
interviews (N = 17).
16 O’Kane, A. A., Mentis, H. M., &
Thereska, E., 2013, ‘Non-static
nature of patient consent:
shifting privacy perspectives
in health information sharing’
Proceedings of the 2013
Conference on Computer
Supported Cooperative Work
(CSCW-2013) 553–562. New
York: ACM
To explore the views of
chronically ill patients and their
carers towards the use of their
personal medical information
and how it has impacted their
perspectives of sharing their
records with healthcare
providers and secondary-use
organisations.
- Eastern England
and the Greater
London area;
England
Diabetic patients (N = 27)
diagnosed with Type I or Type II
diabetes who were in charge of
their own self-care and diabetic
specialists (N = 6): Male (N = 15);
female (N = 12); 18–73 years age
ranges; 2–32 years diagnosis
ranges; patients who had Type I
diabetes (N = 12); patients who
had Type II diabetes (N = 15).
Diabetes health specialists (N = 6).
Theoretical, non-
probabilistic
sampling
(Convenience
sampling to
interview the
diabetes
specialists)
Individual interviews
(patients and specialists)
and a group interview
with 12 patients.
17 Robling, M. R., Hood, K.,
Houston, H., Pill, R., Fay, J., &
Evans, H. M., 2004, ‘Public
attitudes towards the use of
primary care patient record
data in medical research
without consent: a
qualitative study’ Journal of
Medical Ethics 30(1): 104-109
To explore public and lay
opinions about the use of
primary care records for
research when patient consent
has not been sought.
- South Wales Members of the public
participated in the focus groups
(N = 49): participants older than
50 (N = 32; 71 %); participants in a
non-manual social class (N = 36).
Non-medical members of local
community health councils partic-
ipated in the key informant inter-
views (N = 4).
Stratification of
groups by
gender,
geographical
setting and level
of deprivation.
Focus-group meetings
(N = 8) and semi-
structured key informant
interviews (N = 4).
18 Saxena, N., & Canadian Policy
Research Networks. Public
Involvement Network, 2006,
Understanding Canadians'
attitudes and expectations:
citizens' dialogue on privacy
and the use of personal
information for health
research in Canada CPRN=
RCRPP
To explore Canadian’s views
about personal privacy and the
use of personal information for
health research purposes.
April to May 2005 Hamilton, Halifax,
Vancouver,
Montreal, Toronto;
Canada
Members of the public (N = 98):
male (N = 40); female (N = 58).
Age ranges: 20–39 years (N = 37),
40–59 years (N = 35), 60+ years
(N = 26). Women were over-
represented at the dialogue in
comparison to the general popu-
lation (59 % to 51 %, respectively).
Random-digit
dialling
One-day citizen dialogue
sessions in English (N = 5)
and French (N = 2).
19 Spruill, I. J., Gibbs, Y. C.,
Laken, M., & Williams, T.,
2014, ‘Perceptions toward
establishing a biobank and
clinical data warehouse:
Voices from the community’
Clinical Nursing Studies 2(3): 97
To assess community opinions
of the proposed Biobank
practices and policies for
storing biomaterial for future
research, and to determine the
best practice for educating the
public regarding the biobank
and Clinical Data Warehouse
(CDW).
- Charleston,
Beaufort, Berkeley,
Dorchester,
Georgetown and
Horry; South
Carolina, USA
Total participants (N = 67): key
informants (N = 10) and general
community members (N = 57).
Focus-group participants were
mostly African-American females
from Georgetown and Beaufort
counties. The cognitive-interview
sample included key informants
from the faith/scientific community,
medical staff and formal/informal
community leaders.
N/a Focus groups of general
community members
(N = 7) and individual key
informant interviews
(N = 10).
A
itken
et
al.BM
C
M
edicalEthics
 (2016) 17:73 
Page
9
of
24
Table 3 Study characteristics (Continued)
20 Stone, M. A., Redsell, S. A.,
Ling, J. T., & Hay, A. D., 2005,
‘Sharing patient data:
competing demands of
privacy, trust and research in
primary care’ British Journal
of General Practice 55(519):
783-789
To explore the knowledge and
attitudes of patients and
primary healthcare staff
regarding the sharing of data
held in medical records,
particularly for research and
how this may affect trust
between patients and
healthcare professionals.
- Five general
practices in
Leicestershire,
England.
Patients (N = 20) and healthcare
professionals/managers (N = 15).
Purposive and
quota sampling
Semi-structured
interviews
21 TNS 2012, Open Data
Dialogue: Final Report
To examine how open data
principles and policies in
research should be developed
and implemented.
Late February to early
March 2012
Swindon, Oldham
and London;
England
Members of the public (N = 40).
The same participants engaged in
both Wave 1 and Wave 2.
- Primary and secondary
research methods:
Literature and policy review
(N= 1); public-dialogue
workshops (N= 2); stake-
holders mapping and
scoping workshop (N= 1);
and producing a report for
dissemination (N= 1).
22 Trinidad, S. B., Fullerton, S. M.,
Bares, J. M., Jarvik, G. P.,
Larson, E. B., & Burke, W.,2010,
‘Genomic research and wide
data sharing: views of
prospective participants’
Genetics in Medicine
12(8): 486-495
To explore the views of current
and possible future research
participants regarding genome-
wide association studies (GWAS)
and repository-based research.
March to August 2008 Seattle
metropolitan areas,
Washington, USA.
Current research participants in
the Adults Changes in Thought
(ACT) Study; ACT surrogate
decision-makers; and three age-
defined cohorts of Group Health
members not in the ACT Study of
18–34 years, 35–50 years and 50+
years (N = 79). Mean age was
56.4 years; age range was 18–89
years; 48 % female.
Random
sampling
Series of focus-group
discussions (N = 10): Two
sessions were held for
each of the 5-selected
population groups.
23 Trinidad, S. B., Fullerton, S. M.,
Bares, J. M., Jarvik, G. P., Larson,
E. B., & Burke, W., 2012,
‘Informed consent in genome-
scale research: what do
prospective participants think?’
AJOB primary research 3(3): 3-11
To explore the views of
research participants and
members of the general public
toward informed consent and
issues involving genome-wide
association studies (GWAS) and
other similar kinds of genomic
research.
March to August 2008 Seattle,
Washington, USA
Members of the Group Health
Cooperative (N = 45): Mean age
was 45 years; 40 % were female.
Two separate sessions were held
with members aged 18 to 34 years,
members aged 35 to 50 years and
members older than 50 years.
Random
sampling
Focus groups (N = 6)
24 Weitzman, E. R., Kaci, L., &
Mandl, K. D., 2010, ‘Sharing
medical data for health
research: the early personal
health record experience’
Journal of Medical Internet
Research 12(2)
To understand consumer
willingness to share data from
Personally Controlled Health
Records (PCHR) for health
research purposes and to
explore the conditions and
contexts that encourage
willingness to share.
- Urban area within
the northeastern
region of the USA.
Early adopter sample of PCHR users
completed the surveys (N=151).
PCHR usability testers (N=13) were
recruited for the structured
interviews and community members
(N=17) participated in the focus
groups. Average age in the usability
test group was 45 years, reflecting an
employee and student population.
Average age across focus-group
participants was 71 years, drawn
from a retiree and health advocacy
mailing list. Females outnumbered
males in all groups.
- Mixed methods: Surveys,
interviews and focus
groups.
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Table 3 Study characteristics (Continued)
25 Willison, D. J., Keshavjee, K.,
Nair, K., Goldsmith, C., &
Holbrook, A. M., 2003,
‘Patients' consent preferences
for research uses of
information in electronic
medical records: interview
and survey data’ BMJ
326(7385): 373
To determine patients’
preferred method of consent
for the use of information from
electronic medical records for
research purposes.
- Southern Ontario,
Canada
Patients of doctors in the
COMPETE study (N = 123).
Participants interviewed (N = 17):
Male (N = 7); female (N = 11).
Patients who completed a survey
(N = 106).
- Mixed methods: Semi-
structured interviews and
a structured fixed-
response survey
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Table 4 Key themes and sub-themes
Key themes Sub themes Studies
Widespread
Conditional Support
General widespread, yet conditional, support for uses of data in health research. 3, 7, 8, 10, 19, 21, 22, 25
Health research or more general research is typically “in the public interest” or will benefit
“the greater good”.
2, 3, 4, 7, 8, 9, 10, 12, 13, 14, 15,
18, 19, 20, 21, 22, 25
“Doesn’t this happen already?!” 7, 10, 11
Research uses of data were considered to be in the public interest and should therefore be
used, not wasted.
1, 2, 6, 19, 21, 22
Conditions for
Support
Assurances of individuals’ confidentiality are crucial for public support. 2, 3, 4, 5, 6, 9, 11, 14, 17, 18, 21,
22, 24
Public preferences for data to be anonymous. 1, 3, 5, 6, 9, 11, 14,15, 17, 20, 21,
22
If the data is anonymous “What does it matter?!” 6
Anonymisation is not a panacea. 8, 17
Anonymisation is imperfect. 1, 5, 8, 11, 14
Participants made a distinction between “plain stats” and more detailed qualitative
information.
1, 3, 11, 14
Assurances of safeguards in place to protect against misuse or abuse of data were
considered important for ensuring public support and/or acceptability.
1, 7, 8, 10, 11, 14, 18, 19, 21, 22,
24
Public preferences for strong accountability mechanisms to be in place. 4, 5, 12, 14, 18, 22
Low awareness of current research practices. 8, 10, 11, 14, 15, 17, 19, 20, 21,
25
Low public awareness of current governance or ethics processes. 7, 10, 19, 21
Assurances of data security are important for public acceptability of research uses of data. 7, 8, 10, 11, 24
Concerns about data security were widely identified. 1, 5, 6, 8, 11, 14, 20, 22, 24
Concerns about data security related to the fallibility of IT systems to protect against
breaches.
5, 8, 11
Concerns about data security related to human error were widely called upon. 5, 6, 8, 11, 23
Breaches of security were regarded as always being possible, yet security risks were
sometimes said to be tolerated or accepted where individuals valued the purpose and
potential benefits of research.
8, 10, 22
Public support was conditional if data would only be used for legitimate purposes. 8, 11, 19, 21, 22, 25
Benefits Key condition for public support for research using individuals’ data was that such research
must have public benefits.
1, 2, 4, 5, 6, 10, 11, 18, 21, 23, 25
Perceived personal benefits, or personal relevance of research was reported to motivate
participation in research.
7, 11, 13, 19, 23
Concerns relating to personal privacy were balanced with recognition of the importance of
societal benefits anticipated to come from research.
4, 5, 8, 9,14, 15, 17, 21, 22, 24
Societal benefits prioritised over personal privacy. 21, 22
Assurances that research would - or at least have the potential to - bring about public
benefits were fundamental for ensuring public support or acceptance.
1, 2, 4, 5, 6, 10, 11, 18, 21, 23, 25
Control and
Consent
Perceived autonomy, or individual control over how data is used, was found to be a key
factor shaping public responses.
4, 12, 14, 18, 23, 25
Members of the public value having control over their own data. 2, 12, 14, 18, 23, 25
Participants explicitly referred to control over their own data in terms of individual or human
rights.
4, 14, 15, 17, 25
There was an evident link between levels of trust (in research organisations or data
controllers) and desired level of individual control.
4, 25
Individual control needs to be balanced with efficiency of research. 5, 10, 12, 18, 25
Consent as a mechanism for facilitating individual control. 12, 15, 23, 25
Varied views on consent and what form this should take. 2, 11, 12, 14, 20, 22, 23, 24
Public preferences for explicit opt-in consent models. 14, 15, 19, 23
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Table 4 Key themes and sub-themes (Continued)
Public acceptance of opt-out models in recognition of the challenges or practical limitations
of opt-in.
10, 19
Public preference for varied or flexible consent models which would enable individuals to
set limits on their consent, or to indicate particular preferences or objections.
4, 5, 12, 18, 22, 23, 24
Public objections to one-time consent models which would not allow individuals to review
or change their consent preferences.
16, 23, 24
Public opinions or preferences are not fixed but change and adapt in response to
information, deliberation, events or circumstances.
11, 15, 16, 20, 21, 23, 25
Consent was recognised to be problematic. 8, 10, 12, 17, 21, 22, 23
Acknowledgment of the potential for selection bias or low participation rates if explicit opt-
in consent is required.
10
Consent regarded as important in relation to named or identifying data. 5, 20, 21
Consent regarded as important in relation to qualitative information rather than “plain stats”. 3
Consent regarded as important in relation to research using genetic data. 18, 19, 24
Consent regarded as important in relation to where a commercial entity is involved in
research.
18
Consent was widely viewed to be important and in this regard, represented as an act of
courtesy.
8, 17, 20, 23, 25
Uses and Abuses of
Data
A key concern regarding research uses of data was the potential for data to be misused or
abused.
4, 5, 8, 10, 11, 12, 13, 14, 21, 22
Concerns about data being sold or passed on to third parties. 4, 8, 9, 11, 12, 14, 19, 21, 22, 23,
25
Concern about data being used for political purposes. 5, 11, 21, 24
Concerns about potential future uses of data. 5, 9, 11, 12, 13, 19, 21, 22, 23
Concerns about potential “slippery slopes” as more information becomes accessible. 14
Concerns about data being used for purposes other than those which were originally
described.
17, 21, 23
Concerns about the proliferation of data within modern societies and increasing surveillance
through data collection - “Big Brother Society”.
5, 11, 13, 14, 22
Concern related to the potential for stigma or discriminatory treatment to result from
research which would label or categorise groups within society.
1, 5, 6, 8, 11,14,19
Concerns relating to potential indirect negative impacts on individuals from participating in
research (e.g. increased or denied insurance premiums due to information being accessed
from medical records, etc.).
1, 5, 6, 9, 11,12, 17, 24
Participants made differentiations between types of data and regarded some as more
sensitive - and concerning - than others (e.g. mental health, sexual health, sexuality and
religion).
6, 7, 11, 15, 16, 17, 20, 22, 23
Private Sector
Involvement
Concern about private sector involvement in research using individuals’ data. 5, 6, 7, 8, 9, 10, 11, 12, 14, 17, 20,
22, 24
Low levels of public trust in the private sector. 4, 5, 10, 11, 12, 14, 18, 21, 22, 23,
25
Perceptions that private sector organisations are motivated by profit. 6, 10, 11, 20, 22
Distinctions were made between research perceived to be “for profit” and research perceived
to be “for the greater good”.
6, 7, 10, 11, 21, 22, 25
Distinctions were made between “research purposes” and “commercial gain”. 3, 22
Participants wanted assurances that public benefits would be prioritised over profit. 6, 10, 14, 18, 21, 25
Participants wanted assurances that individuals’ privacy would be prioritised over profit. 18
Participants wanted assurances that profits would be shared or reinvested so as to create
public/societal benefits.
6
Participants felt it was appropriate that private sector organisations pay for access to public
sector data.
6, 11, 22
Acceptance of private sector organisations paying for access to public sector data if the
revenue generated is appropriately re-invested in the public sector.
17, 25
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number of studies it was reported that participants
regarded breaches of security as always being possible,
yet security risks were sometimes regarded as tolerable
or acceptable where individuals valued the purpose and
potential benefits of research.21
A further condition for public support was that data
would only be used for legitimate purposes. Whilst the
term “legitimate” was not always referred to explicitly,
the included studies often suggested or concluded that
the extent to which members of the public perceived
uses of data to be legitimate influenced their responses
or preferences.22 However, there were varying views on
how, or by whom, legitimacy was to be defined.
Public Benefits
Another key condition for public support for research
using individuals’ data was that such research must have
public benefits.23 Whilst in some cases perceived per-
sonal benefits, or personal relevance of research was re-
ported to motivate participation in research,24 benefits
of research were largely conceptualised in terms of bene-
fits to wider society, or “the greater good”. For example,
study participants said:
“…We wouldn’t have the national health service, we
wouldn’t have drugs, we wouldn’t have anything, if it
hadn’t have been for people being allowed to try things
Table 4 Key themes and sub-themes (Continued)
Widespread concern about private sector involvement in research balanced by recognition
that private sector involvement in research can be important or valuable.
8, 11, 21, 22
Private sector involvement represented as a “necessary evil”. 6, 7, 8
The private sector was not regarded as a homogenous entity, but rather distinctions were
made between private sector organisations.
6, 8
Private sector involvement was acceptable as long as commercial actors did not have access
to data.
15
Concerns about private sector organisations as funders of research and the implications this
may have for the integrity or objectivity of the research.
5, 10, 15, 21, 25
Ambivalent views on government research. 6, 11, 15
Concern government access to data. 9, 11, 12, 22, 24
High levels of trust in universities and academic researchers. 7, 11, 12, 20, 22
Lack of trust in universities and academic researchers. 4
Trust and
Transparency
Levels of trust individuals place in research organisations, oversight bodies or government
informs their level of support for research uses of data.
2, 4, 6, 11, 14, 22
Trust is essential for ensuring public acceptance and/or participation in research. 2, 4, 6, 8, 9, 11, 13, 14, 21
Higher levels of trust in the public sector compared to the private sector, largely related to
greater confidence in accountability and data protection mechanisms within the public
sector.
6, 11, 21
High levels of public trust in primary healthcare providers. 5, 7, 8, 14, 15, 17, 25
Higher levels of trust in known or familiar individuals or organisations. 4, 17, 20, 22, 24, 25
Preference that data-sharing and research uses of data to be overseen within, and governed
by the public sector.
5, 6, 11
Preference that such processes are overseen and controlled by healthcare professionals (e.g.
known/familiar individuals).
5, 14, 15
To oversee and govern data-sharing and research uses of data may be overly burdensome
to healthcare professionals and take valuable time and resources away from the provision of
healthcare.
17
Participants request for more information about current research practices and uses of data. 2, 4, 5, 6, 7, 9, 10, 11, 12, 13, 14,
15, 19, 21, 23, 24
Transparency as to how data is used for research purposes is considered crucial for building
public trust, and consequentially securing public support.
12, 14, 18, 21
The importance of awareness raising to build trust and public support is emphasised in
certain studies.
6, 7, 11, 14, 15, 18, 19
There is public interest and enthusiasm for more meaningful forms of public engagement/
involvement.
5, 6, 11
Public engagement/involvement is essential for ensuring accountability. 5, 6, 15
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out in the past. So, I suppose, when you look at it like
that, it is almost as if you have a moral duty to say,
we have benefited, so why shouldn’t we contribute for
[future generations?]”25
In many cases it was reported that concerns relating
to personal privacy were balanced with recognition of
the importance of societal benefits anticipated to come
from research.26 Moreover, in two studies it was re-
ported that some participants prioritised societal benefits
over personal privacy.27
Assurances that research would bring about public
benefits—or at least that it had the potential to bring
about such benefits—were widely reported to be funda-
mental for ensuring public support or acceptance. If re-
search is perceived to be focussed primarily at benefitting
individual researchers (e.g. through advancing their ca-
reers or raising their profile), as having no clear practical
application or “real-world” value, or as being conducted
solely for profit this leads to concerns and opposition (or
at least less support) for research uses of data.28
Control and Consent
Perceived autonomy, or individual control over how data
is used, was found to be a key factor shaping public re-
sponses in a number of studies.29 It was reported that
members of the public valued having control over their
own data.30 Such control relates to what data are col-
lected, who has access to this, how and with whom data
is shared and for what purposes the data are used. In a
number of studies participants explicitly referred to this
control in terms of individual or human rights.31
Whilst perceived individual control clearly emerged as a
key factor shaping public attitudes or acceptance of re-
search uses of data, there was no clear consensus (across
or within) the studies regarding what this control implied
or necessitated. In some studies there was a clear link be-
tween levels of trust in research organisations or data con-
trollers and desired level of individual control.32 This
suggests that where individuals trust organisations hand-
ling their data they are less likely to favour more stringent
forms of control. Conversely, when this trust is lacking in-
dividuals want to have greater control over their own data.
Preferences for control are also influenced by wider
attitudes towards the value of research. In a number
of studies it was found that, whilst individual control
was highly valued, participants did not want this
control to come at the cost of creating barriers to
research. Thus it was often found that participants
felt that individual control needs to be balanced with
efficiency of research.33
Across the included studies control is largely discussed
in relation to consent. There is evidence that members
of the public also made this association and recognised
consent as a mechanism for facilitating individual con-
trol.34 However, both between and within studies there
were varied views on consent and what form this should
take.35 Some studies indicated public preferences for
explicit opt-in consent models,36 whilst an acceptance of
opt-out models was also reported due to recognition of
the challenges or practical limitations of opt-in.37 In a
significant number of studies there was a clear prefer-
ence for varied or flexible consent models which would
enable individuals to set limits on their consent or to in-
dicate particular preferences or objections.38 Similarly,
some studies reported that participants objected to one-
time consent models which would not allow individuals
to review or change their consent preferences.39 This
relates to the fact that public opinions or preferences are
not fixed but change and adapt in response to informa-
tion, deliberation, events or circumstances.40
Whilst consent was widely valued as a mechanism for
facilitating individual control in many studies, it was also
recognised to be problematic.41 In particular participants
in the studies acknowledged the potential for selection
bias or low participation rates if explicit opt-in consent
is required. Such recognition led to some individuals
becoming more inclined to support opt-out consent
models or non-consented uses of data, however this
trend was certainly not universal and others maintained
that consent was always important.
The included studies highlight a number of areas
where consent was regarded as particularly important,
for example in relation to named or identifying data,42
qualitative information rather than “plain stats”,43 re-
search using genetic data44 or where a commercial entity
is involved in research.45
Where consent was acknowledged to be problematic
and/or where individuals reported that they were largely
unconcerned about research uses of data, consent was
nevertheless widely viewed to be important. In a number
of studies consent was in this regard represented as an
act of courtesy with participants suggesting that they
would be happy to allow their data to be used for re-
search but that this should nonetheless not be used
without their permission.46
Uses and Abuses of Data
A key area of concern regarding research uses of data re-
lated to the potential for data to be misused or abused.47
In some cases this related to concerns that individuals
with access to data would use it maliciously or inappro-
priately, for example it was stated that:
“there are some people, [that] regardless of the
consequences will defy rules and regulations to justify
their existence or to prove they can do it…”
(Damschroder et al. 2007: 231)
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In other instances these concerns related to data being
sold or passed on to third parties48 and used for com-
mercial purposes, e.g.:
“What I don’t like is any information being passed on
to a third party, for promotion purposes. Say you’ve got
a particular problem then it goes to a drugs supplier
or something like that, that I would object to.”
(Participant 4, group 1, Hill et al. 2013: 6)
There was also concern about data being used for pol-
itical purposes,49 e.g.:
“If the Government are using the details for the benefit
of society, I think that’s okay. But if the Government
are using that data to then look at their next election
campaign, or look at the independence campaign by
looking at the demographics of a particular area, then
I don’t know if that’s as acceptable. They’[d] simply be
using our data for their own goals” (Female, aged
18–34, Glasgow, Davidson et al. 2013).
Some participants in the studies expressed concerns
about potential future uses of data.50 While current uses
or research objectives may be regarded as acceptable
participants expressed scepticism that such uses would
remain clearly defined and limited. Some study partici-
pants were worried about potential “slippery slopes” with
more and more information becoming accessible51 or
with data being used for purposes other than those
which were originally described.52
There were also concerns about the proliferation of
data within modern societies and increasing surveillance
through data collection. For some these concerns were
expressed in relation to the creation of a “Big Brother So-
ciety”,53 e.g.:
“You can’t move. You can’t do anything without
somebody, somewhere knowing exactly what you’re up
to” (Female, depth interview, MRC & Ipsos-MORI
2007: 25)
A significant area of concern related to the potential
outcomes or implications of research. In particular, study
participants were concerned about the potential for
stigma or discriminatory treatment to result from re-
search which would label or categorise groups within so-
ciety,54 e.g.:
“I think research maybe tends to lump everybody
together, and there must be individuals that would be
totally different […] so it could lump everybody
together and maybe that’s not what we want.”
(Tayside—Female4, Aitken 2011: 12)
“Some universities might feel: ‘we don’t want to involve
people from areas of deprivation, because we know
they are less likely to finish their course and that’s bad
for us, for our figures’” (Male, oldest age group,
Edinburgh) (Davidson et al. 2013: 70)
There were also concerns relating to potential indirect
negative impacts on individuals from participating in re-
search.55 For example, a frequent concern related to po-
tential for insurance premiums to increase or be denied
as a result of information being accessible from medical
records. Additionally there was concern that employers
may gain access to information which could be used
to the detriment of individual employees. Participants
were concerned that data which was shared could be
accessed and used in ways which could be harmful
for individuals, e.g.:
“Money’s money but health is how you feel as well and
if you’re being persecuted in a way because of that, it’s
just going to make you worse” (Female, depth
interview, MRC & Ipsos-MORI 2007: 29).
“People can judge them, so if they find out something
about you because of your health you could be picked
on” (Female, depth interview, MRC & Ipsos-MORI
2007: 29).
Such concerns were particularly salient in relation to
more sensitive forms of data. Across the studies it was
reported that participants differentiated between types of
data and regarded some as more sensitive—and concer-
ning—than others.56 Examples of particularly sensitive
forms of data include data relating to mental health,
sexual health, sexuality and religion.
Private Sector Involvement
Across the studies there was significant concern about
private sector involvement in research using individuals’
data.57 Such concerns largely related to two key factors:
low levels of public trust in the private sector58 and a
perception that private sector organisations are pri-
marily—or solely—motivated by profit.59 Across the
studies participants often made distinctions between
research which was perceived to be “for profit” and
research perceived to be “for the greater good”.60
Similarly, distinctions were made between “research
purposes” and “commercial gain”61 as if they were op-
posing motivations. As noted above, the creation of
public benefits from research was widely regarded as
an essential prerequisite for public support or accept-
ance. Therefore, where participants regarded research
to be conducted for purposes other than creating
public benefits this raised concerns.
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However, such concerns did not necessarily mean out-
right opposition to private sector involvement in re-
search. Profit-creation resulting from research was
regarded as acceptable under certain conditions. Not-
ably, the included studies indicated that participants
wanted assurances that public benefits would be priori-
tised over profit,62 that individuals’ privacy would be
prioritised over profit63 and that profits would be shared
or reinvested so as to create public/societal benefits.64
Additionally, while there were concerns about individ-
uals’ data being sold, studies which explored private sec-
tor access of public sector data found that participants
often felt it was appropriate that private sector organisa-
tions pay for access to these data65 and that this would
be regarded as acceptable on the condition that revenue
generated is appropriately re-invested in the public
sector.66
While there was widespread concern about private
sector involvement in research this was often balanced
by a recognition that private sector involvement in re-
search can be important or valuable.67 In some cases
private sector involvement was represented as a “neces-
sary evil”,68 e.g.:
“… the drug companies are just trying to make money,
and yes of course they are, it’s all about money in the
end of the day but if they don’t find the research for
some of these the less interesting or less topical things
then they, there will not be research into those things…
we need to get funding from drug companies anyway,
if they’re the ones with the money.” (Female, patient
focus group 3, PPG, Grant et al. 2013: 8).
Thus profit-creation was regarded by some study par-
ticipants to act as an incentive for private sector organi-
sations to conduct valuable research in the public
interest.
Overall, the included studies demonstrate that mem-
bers of the public hold nuanced and complex views re-
garding private sector involvement. It is noteworthy that
the private sector was not regarded as a homogenous
entity, but rather distinctions were made between private
sector organisations.69 There was also acknowledgement
of the different roles that private sector organisations
can play in research. For example it was reported in one
study that private sector involvement was acceptable as
long as commercial actors did not have access to data.70
Other studies reported concerns about private sector or-
ganisations as funders of research and the implications
this may have for the integrity or objectivity of the
research.71
Whilst low trust in private sector actors is frequently
reported, the included studies also demonstrate complex
or ambivalent relationships of trust in actors from other
sectors. For example, several studies identified ambiva-
lent views on government research72 and concern about
government access to data.73 Additionally, whilst some
studies reported high levels of trust in universities and
academic researchers74 one reported a lack of trust in
university researchers.75 Thus relationships of trust are
not straightforward and there does not appear to be a
clear, or static hierarchy of trusted organisations/sectors.
Trust and Transparency
Trust is a key theme running through all of the included
studies (both implicitly and explicitly). A number of
studies indicated that the level of trust individuals place
in research organisations, oversight bodies or govern-
ment, informs their level of support for research uses of
data.76 The included studies indicate that trust is essen-
tial for ensuring public acceptance and/or participation
in research.77
As noted above, relationships of trust are nuanced and
complex. However the included studies indicate gener-
ally higher levels of trust in the public sector compared
with the private sector, largely related to greater confi-
dence in accountability and data protection mechanisms
within the public sector.78 There is also evidence of par-
ticularly high levels of public trust in primary healthcare
providers.79 This reflects a trend of higher levels of trust
in known or familiar individuals or organisations,80
which was exemplified in study participants’ confidence
in particular healthcare professionals to make good
judgements on access to patients’ data:
“I know my physician well enough to have a good feel
for the types of things he would be involved with”
(Patient 12, Nair et al. 2004: 25).
“If you trust the doctor, I don’t think it would worry
me how much [data] you needed, and I do trust the
doctor” (Patient 15, Nair et al. 2004: 25).
It also leads to individuals preferring to be contacted
only by healthcare professionals, or known individuals:
“I am happy to have personal contact with our
hospital, GP or the health professionals who knows me,
but I am not happy being contacted by a Pfizer company,
or whatever” (MRC & Ipsos-MORI 2007: 19).
Participants in the included studies often expressed a
preference that data-sharing and research uses of data
be overseen within, and governed by, the public sector.81
In some instances there was a preference for such pro-
cesses to be overseen and controlled by healthcare pro-
fessionals (e.g. known/familiar individuals).82 However,
some study participants acknowledged that this may be
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overly burdensome and take valuable time and resources
away from the provision of healthcare.83
The importance of relationships and familiarity to trust
is indicative of a broader desire for greater transparency
about research practices. The included studies over-
whelmingly suggest an appetite among study participants
for more information about current research practices
and uses of data.84 Transparency about how data is used
in research is considered crucial for building public trust,
and thereby securing public support.85 Moreover, many of
the included studies point towards the importance of
awareness raising for building trust and public support.86
However, the included studies highlight that the public
should not be conceived of as simply subjects of informa-
tion provision relating to research uses of data. Rather,
several studies indicate public interest and enthusiasm for
more meaningful forms of public engagement/involve-
ment.87 Such involvement was considered essential for
ensuring accountability.88
Differences between studies
It is not possible to make clear or consistent compari-
sons between the findings of the included studies due to
different social and cultural contexts. For example, in a
Japanese study89 participants were reported to describe
“unequal relationships” between patients and doctors
with patients belonging to a “lower rank”. This may
reflect (actual or perceived) traditional doctor-patient re-
lations in Japan that are more hierarchical and paternal-
istic [20]. However, discussions of unequal relationships
in other studies were not explicitly reported though
some study participants may have implicitly referred to
them. Diverse study populations also limit the findings
from being comparable. These smaller populations in-
clude U.S. veterans reporting higher levels of trust and
greater support for research by Veteran Affairs90; African
Americans expressing lower willingness to engage in gen-
etic/genomic research due to past abuses91; and LGBT
participants in the U.K. concerned for the misuse of data,
particularly identifiable data, that could lead to discrimin-
ating opinions and behaviour.92 These findings build on
previous research reporting concerns over the underrepre-
sentation of minority populations in research, such as
African Americans [21–23] and LGBTs [24]. While these
views may not be comparable to other contexts, they are
indeed essential to understanding the needs of different
social groups to better inform a wide variety of policies
and practices. Despite variations in opinion, the overall
views of these study populations were consistent with the
general findings of the thematic synthesis.
A further limitation to the review was the underrepre-
sentation of young people across the studies. Of the few
studies that compared all age groups, the variations in
opinion were detailed. Two studies reported that
younger participants expressed greater concerns for
privacy and a desire for control over research data.93
Another noted that some felt “anxious” about their data
being held while others believed they had little control
over their own information.94 In contrast, older partici-
pants were reported to favour less individual control95
or to be less worried about the possible loss of confiden-
tiality.96 Previous research by Buckley et al. [25] equally
commented on the lack of participation of younger
people in their study. The few that responded, were
more cautious about the use of their medical informa-
tion compared to older participants. However, the
researchers were wary of these results due to the unrep-
resentativeness of the sample. Additionally, there are
some contradictory findings, for example, King et al.
[26] found that younger participants and older respon-
dents over the age of 60 were less concerned about the
privacy of their health information compared to partici-
pants in the mid age range. King et al. [26] suggested
this may be due to the “carefree” nature of younger gen-
erations who were perceived to be more willing to share
their personal information (e.g. on social-networking
sites) and older respondents who are no longer invested
in their career and therefore under less scrutiny. More
recently the Wellcome Trust [3] found a non-linear rela-
tionship between acceptance of commercial access to
health data and age and noted that young people are not
automatically more supportive/accepting. These varying
and, at times, conflicting findings point to the need for
greater research to explore the variations in perceptions
and opinions across age groups.
Finally, the authors conducted a broad search of public
responses to data sharing and data linkage in research
that included studies looking at genetic data97 and
medical-records data.98 These topics were considered to-
gether with other papers discussing health, personal or
administrative data or information for statistical, health,
social or other research purposes. Some studies suggest
genetic data is particularly sensitive99 or personal/poten-
tially identifying.100 In one study, participants perceived
genetic data to be potentially less sensitive than informa-
tion from medical records (e.g. information relating to
reproductive or mental health).101 Participants’ from an-
other study reported no real variation in attitudes toward
the use of medical records and biological samples.102 In
some studies, linking medical records data to biological
samples raises concerns.103 However, overall opinions
were largely consistent with the key themes of this review.
Discussion
The included studies point towards widespread support
for uses of data in research, including for practices of
data-linkage and data-sharing. However, this support is
never unconditional. Key conditions for public support
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or acceptance relate to the research being in “the public
interest” or for “the greater good” and to public trust in
researchers or organisations handling/accessing their
data. The themes of public benefits and public trust run
through all the studies (explicitly or implicitly) and
underpin all other areas of concern or interest. As has
been noted elsewhere [27] trust—or trustworthiness—is
increasingly recognised as being central in shaping pub-
lic responses. However, the included studies do not point
to clear relationships or hierarchies between particular
areas of concern or conditions for support and there is a
lack of evidence relating to the ways in which trade offs
might be made or how preferences would be formed in
reality. This may represent a valuable area to explore
further in future research.
As the literature in this area has frequently observed,
confidentiality is a key area of public concern and assur-
ances of confidentiality appear to be important for ensur-
ing public support. However, in the wider literature
relating to secondary uses of data in health research there
has been much debate about the value and implications of
anonymisation which is frequently described as represent-
ing significant challenges [28–30]. For example, it is ar-
gued that a certain amount of identifying information is
needed in order to allow updating, linkage or validation of
data [30, 31]. Ohm has argued that ‘data can either be use-
ful or perfectly anonymous but never both’ [32] (p.1704).
Despite these challenges relating to anonymisation, confi-
dentiality is largely discussed and understood in terms of
anonymisation. The included studies which explored pub-
lic attitudes towards confidentiality typically focussed on
attitudes towards anonymisation of data.
Anonymisation is generally understood as the process
of removing key identifiers such as names and dates of
birth from personal data thus rendering the identifica-
tion of subjects highly unlikely. However, anonymisation
is not straightforward and, as the MRC & Wellcome
Trust suggest: ‘Because identifiability runs a spectrum,
anonymisation is relative’ [2] (p.10). The UK Information
Commissioner’s Office (ICO) has stated that ‘[i]n reality
it can be difficult to determine whether data has been
anonymised or is still personal data’ [33] (p.16). This am-
biguity around anonymisation has implications for un-
derstanding public responses in this area, as Haddow
et al. note, where studies have explored public attitudes
‘it is often unclear whether the research into publics’
views relates to fully anonymised data, the use of weaker
forms of anonymisation or indeed fully identifiable data
[34] (p. 1141). Therefore whilst studies have reported
public attitudes towards anonymisation it is not always
clear what members of the public understand anonymi-
sation to mean, or what they perceive it to require.
There is evidence within the included studies that assur-
ances of anonymisation may be important for members of
the public, however those studies which enabled greater
reflection on the implications or practicalities of anonymi-
sation (e.g. through deliberative methods) typically uncov-
ered more nuanced positions with members of the public
often acknowledging that anonymisation is imperfect as a
mechanism for protecting confidentiality and/or problem-
atic for facilitating valuable research. Thus, anonymisation
is not regarded as a panacea for addressing public con-
cerns and it may be fruitful to explore further public atti-
tudes towards confidentiality—and the ways that this
might be ensured—beyond anonymisation of data.
Similarly, whilst the extant literature in this area has
focussed heavily on the role and challenges of consent in
relation to data-sharing or data-linkage for research pur-
poses, the included studies highlight that this may not
be a fundamental requirement for public acceptability.
Rather, the studies indicate that whilst autonomy—or
individual control over one’s data—is highly valued, con-
sent is acknowledged to be problematic. As in discus-
sions of anonymisation, where study participants have
had opportunities to reflect on and discuss consent,
views typically shift from an initial preference for explicit
opt-in consent, towards more flexible models of either
opt-out or varied consent. In some cases where study
participants have been convinced of the value of re-
search and the potential for public benefits consent has
been regarded as non-essential. However, the degree of
control individuals describe as necessary relates to the
extent to which they trust the institutions, organisations
or individuals involved in processing or accessing their
data. A recent study conducted by Ipsos Mori on behalf
of the Wellcome Trust found that whilst participants in
their deliberative workshops initially tended to express
preferences for opt-in consent models through the delib-
erative process, they shifted to a position where they
“felt that if they knew more about the processes and
safeguards in place they might feel more empowered,
and hence more open and trusting in the decision-
making process around data collection and sharing (and
may not, therefore, need to opt-in)” [3] (p.13). Control
may be facilitated through transparency and public en-
gagement rather than direct or specific opt-in consent.
As such, the findings reported in the included studies
suggest that rather than focussing on which consent
mechanisms are most favoured by members of the pub-
lic, it may be more valuable to focus on how relation-
ships of trust are built up (and conversely eroded) and
how trust can be facilitated within research and data-
sharing or data-linkage processes including through
public/patient engagement or involvement.
This represents an important finding of this review.
The literature has often suggested consent may be a re-
quirement for public acceptability, whilst simultaneously
arguing that requirements for consent present obstacles
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to effective and necessary health research and/or surveil-
lance [29, 30, 35]. One alternative to consent which is
currently used in the United Kingdom and elsewhere is
authorisation. In England, for example, the Confidential-
ity Advisory Group (CAG) advises on requests to access
data for research where neither consent nor anonymisa-
tion are deemed practicable. Similarly, the Public Benefit
and Privacy Panel (PBPP) in Scotland is responsible for
advising on data access requests involving personal data
held by Information Services Division (ISD) of NHS
National Services Scotland (NSS) and NRS (National
Records of Scotland). Authorisation is now a widely used
governance mechanism and authorising bodies play a
significant role within the data sharing landscape. How-
ever, this review has found that to date the literature has
not engaged with the subject of authorisation and there
is a lack of evidence on public awareness of, or responses
to, authorisation as a governance mechanism. The findings
that individual level consent may not be crucial for public
acceptance and that trust in organisations and institutions
may be more important in shaping public responses, point
to the salience of public engagement relating to authorisa-
tion approaches. Future research ought to explore public
responses to authorisation.
As well as highlighting important conditions for public
support, the included studies also indicate a number of
areas of public concern about research uses of data.
These relate largely to the purposes the research is per-
ceived to serve, and the extent to which it is considered
to be in the public interest or likely to yield public bene-
fits. There is significant concern about potential misuse
or abuse of data with negative implications for individ-
uals, however there are also concerns about the potential
for wider negative impacts from the outcomes of re-
search. These relate to: the potential for data-sharing or
data-linkage to enable, or perpetuate mass surveillance
and a perceived “Big Brother Society”; the potential for
individuals or groups within society to be labelled as a
result of data-linkage research and for such labelling to
result in stigma or discriminatory treatment, and to; the
potential for research based on analysis of large data-sets
to be used to inform policies or practices designed “for
the masses” rather than reflecting individual circum-
stances and needs. What is apparent in relation to all
these concerns is the underlying questioning of whether
the research and its potential impacts/outcomes are per-
ceived to be in the public interest or likely to bring
about public benefits. The potential for research to lead
to harm (directly or indirectly) is an area of significant
concern.
The studies identified in this review reveal generally
lower levels of trust in private sector actors compared
with public sector actors alongside concern about pri-
vate sector involvement in research. These concerns are
often related to profit creation from use of individuals’
data and/or perceptions that data is routinely sold or
passed on within the private sector. However, the studies
do not suggest widespread opposition to private sector
involvement, indeed many study participants acknowl-
edged the important role of private sector actors in con-
ducting or facilitating valuable research. Public support/
acceptance of private sector involvement was largely
conditional on the extent to which the research was per-
ceived to be in the public interest or to lead to public
benefits (as has recently been found by the Wellcome
Trust [3]). Profit creation largely was not perceived as a
problem so long as public benefits were prioritised over
profits. The extent to which this was expected to be the
case depended on the level of trust study participants
had in the individuals or organisations handling/acces-
sing data.
An important observation to emerge from this thematic
synthesis is the public’s appetite for more information
about current research and data-sharing or data-linkage
practices. Many of the included studies reveal that there is
generally very low public awareness of current research
practices and governance systems or safeguards in place.
There is evidence that those studies which used delibera-
tive methods and provided participants with opportunities
to learn more about current, or planned practices led to
greater support/acceptance, or less concern about re-
search uses of data. Additionally, almost all included stud-
ies reported that participants expressed a desire for more
information and/or greater transparency about the ways
in which data are used in research and the safeguards in
place to protect against misuse/abuse or harms. This is
significant and indicates not only that more awareness
raising is needed but also that there may be significant en-
thusiasm amongst the public to engage more directly with
and in these forms of research. Awareness raising should
not be approached as a simple process of one-way infor-
mation provision but rather requires a more engaged ap-
proach in order to ensure that it addresses public
interests, concerns or uncertainties. The findings reported
in the literature indicate that greater transparency may be
needed, however, as we have previously noted, “research/
researchers will be more likely to be perceived as trust-
worthy if transparency and public engagement involve
open dialogue with members of the public and opportun-
ities for deliberation, rather than controlled dissemination
of information” [27] (p.9).
Within the included studies members of the public
have been conceptualised in a number of ways. Some
studies have suggested that uses of data in research—and
particularly data-linkage—is a complex area which is dif-
ficult for members of the public to understand or mean-
ingfully engage with. This leads to suggestions that
awareness raising should be used to reassure members
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of the public through simple information provision and
reflects a deficit model approach to public understand-
ing of science [36].104 However, those studies which in-
volved deliberative methods have demonstrated that
members of the public were able and enthusiastic to en-
gage in discussions on this subject and were competent
and valuable deliberators.105 The nuanced positions de-
scribed within the included studies highlight the value of
qualitative methods for not only revealing but also
informing and developing public attitudes. In this way
qualitative methods themselves—as forms of public
engagement—may have a role to play in building trust
which in turn may underpin greater support for second-
ary uses of data. In this way increased use of qualitative
methods might be a building block for support. Such
public engagement and qualitative research are increas-
ingly frequent components of large science projects and
represent, in part, efforts to increase public trust and to
ensure Responsible Research and Innovation (RRI) [27].
Overall this thematic synthesis has also revealed that
there is great scope for qualitative methods to be used
more fully or effectively in this area. This thematic syn-
thesis has focussed only on qualitative studies—or quali-
tative findings reported within mixed methods
studies—yet in some cases qualitative methods had been
used primarily to inform the design of quantitative stud-
ies.106 Moreover, ten studies were excluded at the final
stage due to their limited reporting of qualitative findings
or their narrow, structured approach (e.g. qualitative
methods being used to examine public responses to nar-
rowly defined questions/hypotheses). Therefore it appears
there may be a tendency for qualitative methods to be used
largely as a means for informing subsequent quantitative
methods, which in turn suggests an under-appreciation of
the value of qualitative methods. Indeed, there is some evi-
dence that qualitative methods may at times not be recog-
nised as research methods. The authors found that only
just over half of the included studies107 explicitly referred to
ethical review procedures relating to the qualitative re-
search while researchers in one study specifically stated that
ethical approval was not required.108
Study Limitations
Qualitative studies are sometimes criticised for their lim-
ited generalisability due to small and/or unrepresentative
samples, such criticisms might be levied at the included
studies within this thematic synthesis. The sample sizes
ranged from 14 to 217 participants with the average
being 54.84. Moreover, many of the included studies fo-
cussed on particular groups such as those with particular
health conditions/susceptibilities,109 particular socio-
demographic groups110 or with previous experience with
research and/or data-sharing.111 Additionally, it is im-
portant to note that while random or quota sampling
was often used112 the qualitative methods relied upon
people volunteering to participate in the research which
often involved a significant time commitment. Thus it
might be speculated that those individuals who partici-
pated in these studies were more likely to be supportive
of—or at least interested in—research and individuals
who are less supportive, or more sceptical of research
might have been less inclined to participate. Whilst these
factors mean that the studies cannot be taken as being
representative of the views of the wider public they re-
main valuable as indicators of the range of views within
the public and particularly as illustrating how opinions
are expressed and how they may be informed or influ-
enced. This synthesis of the included studies has ad-
dressed some of the criticisms directed at qualitative
studies in giving increased breadth through synthesising
findings from a large (total) number of study partici-
pants and in a variety of contexts.
Conclusion
With ever-growing interest in secondary uses of data for
health research, including practices of data linkage and
data sharing, there has increasingly been attention di-
rected at public acceptability of these practices. Public
acceptability is recognised as crucial for ensuring the le-
gitimacy of current practices and systems of governance.
This systematic review and thematic synthesis has
highlighted a growing body of evidence pointing towards
widespread general—though conditional—support for
data linkage and data sharing for research purposes. It
has found that whilst a variety of concerns are raised
(e.g. relating to confidentiality, individuals’ control over
their data, uses and abuses of data and potential harms
arising) where members of the public perceive there to
be actual or potential public benefits arising from re-
search and where they have trust in the individuals or
organisations conducting and/or overseeing data link-
age/sharing they are generally supportive. However, the
thematic synthesis has also highlighted current low
levels of awareness about existing practices and uses of
data, it points towards the need for greater awareness
raising combined with opportunities for public engage-
ment and deliberation. This will be important for ensur-
ing the legitimacy of future health informatics research
and for avoiding further public controversy.
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Appendix 1
Adapted search strategy used in medline
1. (Lay or patient* or public or citizen$1).mp. [mp =
title, abstract, original title, name of substance
word, subject heading word, keyword heading word,
protocol supplementary concept word, rare disease
supplementary concept word, unique identifier]
2. exp Patients/
3. 1 or 2
4. (Attitude* or view$1 or perspective* or
opinion$1).mp. [mp = title, abstract, original title,
name of substance word, subject heading word,
keyword heading word, protocol supplementary
concept word, rare disease supplementary concept
word, unique identifier]
5. exp attitude to health/ or health knowledge,
attitudes, practice/
6. 4 or 5
7. 3 and 6
8. exp Public Opinion/
9. 7 or 8
10.(Record$1 or data).mp. [mp = title, abstract, original
title, name of substance word, subject heading
word, keyword heading word, protocol
supplementary concept word, rare disease
supplementary concept word, unique identifier]
11.(Share* or sharing or link$2 or linkage).mp. [mp =
title, abstract, original title, name of substance
word, subject heading word, keyword heading word,
protocol supplementary concept word, rare disease
supplementary concept word, unique identifier]
12.10 and 11
13.exp Medical Record Linkage/
14.12 or 13
15.Research.mp. [mp = title, abstract, original title,
name of substance word, subject heading word,
keyword heading word, protocol supplementary
concept word, rare disease supplementary concept
word, unique identifier]
16.*research/ or exp behavioral research/ or exp
biomedical research/ or exp community-based par-
ticipatory research/ or exp empirical research/ or
exp human experimentation/ or exp operations re-
search/ or exp parapsychology/ or exp peer review,
research/ or exp research design/ or exp research
report/ or exp social validity, research/
17.15 or 16
18.(Access or purpose$1).mp. [mp = title, abstract,
original title, name of substance word, subject
heading word, keyword heading word, protocol
supplementary concept word, rare disease
supplementary concept word, unique identifier]
19.17 and 18
20.9 and 14 and 19
21.(qualitative or ethnograph* or “grounded theory” or
“in depth interview$1” or “*structured interview$1”
or “focus group$1” or “case study” or “case studies”
or “case series” or “citizen$2 jury” or “citizen$2
juries” or vignette* or observation*).mp. [mp = title,
abstract, original title, name of substance word,
subject heading word, keyword heading word,
protocol supplementary concept word, rare disease
supplementary concept word, unique identifier]
22.exp qualitative research/
23.*Interview/
24.exp Focus Groups/
25.exp Observation/
26.21 or 22 or 23 or 24 or 25
27.20 and 26
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